SEC Form 4 · accession 0001193125-26-365484
Parabilis Medicines, Inc. · PBLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig Tendler
Director
Period of report
Aug 22, 2026
Accepted (ET)
Aug 25, 2026 · 6:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001657677
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $39.36 | Aug 22, 2026 | A | 20,294 | A | — | Aug 21, 2036 | Common Stock | 20,294 | 20,294 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from August 22, 2026, subject to the Reporting Person's continued service on each such vesting date.